case_images: PMC8131137_01
case_images: Image of lesion at 1 month (a) and image of lesion at 6 months (b). The mass showed progressive enlargement in size with surface ulcerations.
case_images: CRIM2021-6682960.001.jpg
case_images: PMC8131137_01_CRIM2021-6682960.001.jpg
case_images: fig1
case_images: Contrast-enhanced CT demonstrating right parietal vividly enhancing scalp lesion without involvement of the skull (a). Contrast-enhanced MRI also showing vivid enhancement (b).
case_images: CRIM2021-6682960.002.jpg
case_images: PMC8131137_01_CRIM2021-6682960.002.jpg
case_images: fig2
case_images: The gross findings showing a skin-covered polypoid firm mass (a) with solid tan-white cut surface (b).
case_images: CRIM2021-6682960.003.jpg
case_images: PMC8131137_01_CRIM2021-6682960.003.jpg
case_images: fig3
case_images: On sectioning, the cut surface showed solid tan-white appearance as shown in Figures 3(a) and 3(b).
case_images: H&E microscopic findings. (a) A low-power view of sheets of polygonal cells with variably fibromyxoid stroma. (b) A high-power view showing the classic rhabdoid profile, comprising abundant cytoplasm with eosinophilic hyaline globules and vesicular nuclei with prominent nucleoli.
case_images: CRIM2021-6682960.004.jpg
case_images: PMC8131137_01_CRIM2021-6682960.004.jpg
case_images: fig4
case_images: The background stroma is fibromyxoid with high mitotic activity in addition to areas of necrosis as shown in Figures 4(a) and 4(b).
case_images: Immunohistochemical findings. (a) EMA showing strong positivity in the tumor cells. (b) Loss of nuclear INI-1 staining in the tumor cells with positive internal control (endothelial cells).
case_images: CRIM2021-6682960.005.jpg
case_images: PMC8131137_01_CRIM2021-6682960.005.jpg
case_images: fig5
case_images: PMC8131137_02
case_images: PMC8131137_03